Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: CNS Oncol. 2014 Jul;3(4):257–265. doi: 10.2217/cns.14.29

Table 2.

Grade ≥2 adverse events related to temozolomide 3/11 treatment regimen.

Toxicity Grade 2 Grade 3
Constipation 2
Diarrhea 1
Fatigue 2
Myalgia 1
Nausea 1 2
Thrombocytopenia 1
Vomiting 2
Leukopenia 1
Lymphopenia 3 6